Response by Butt et al to Letter Regarding Article, "Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial"

被引：1
作者：
Butt, Jawad H. [1 ,2 ]
Solomon, Scott D. [3 ]
McMurray, John J. V. [1 ]
机构：
[1] Univ Glasgow, British Heart Fdn Cardiovasc Res Ctr, Glasgow, Scotland
[2] Copenhagen Univ Hosp Rigshospitalet, Dept Cardiol, Copenhagen, Denmark
[3] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA USA
来源：
CIRCULATION | 2023年 / 147卷 / 14期
关键词：
D O I：
10.1161/CIRCULATIONAHA.123.064052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1119 / 1120
页数：2
相关论文
共 50 条
[41]   Letter by Neumann et al Regarding Article, "Myostatin Regulates Energy Homeostasis in the Heart and Prevents Heart Failure" [J].
Neumann, Dietbert ;
Luiken, Joost J. F. P. ;
Nabben, Miranda ;
Glatz, Jan F. C. .
CIRCULATION RESEARCH, 2015, 116 (10) :E95-E96
[42]   Influence of achieved LVEF on efficacy of dapagliflozin in patients with heart failure with improved ejection fraction: the DELIVER trial [J].
Siqueira, S. R. O. ;
Pabon, M. ;
Vaduganathan, M. ;
Claggett, B. ;
Lam, C. ;
Kosiborod, M. ;
De Boer, R. ;
Shah, S. ;
Fang, J. ;
Desai, A. ;
Jhund, P. ;
Inzucchi, S. ;
Mcmurray, J. ;
Solomon, S. ;
Vardeny, O. .
EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 :147-147
[43]   Response by Mele et al to Letter Regarding Article, "Novel Echocardiographic Approach to Hemodynamic Phenotypes Predicts Outcome of Patients Hospitalized With Heart Failure" [J].
Mele, Donato ;
Pestelli, Gabriele ;
Lloyd Dini, Frank ;
Dal Molin, Davide ;
Smarrazzo, Vittorio ;
Trevisan, Filippo ;
Andrea Luisi, Giovanni ;
Ferrari, Roberto .
CIRCULATION-CARDIOVASCULAR IMAGING, 2020, 13 (06)
[44]   Letter regarding article by O'Neill et al, "Peak oxygen consumption as a predictor of death in patients with heart failure receiving β-blockers" -: Response [J].
Lauer, MS ;
O'Neill, JO ;
Pothier, CE ;
Young, JB .
CIRCULATION, 2005, 112 (16) :E271-E271
[45]   Letter regarding article by Armstrong et al, "Lessons learned from a clinical trial" - Response [J].
Armstrong, PW ;
Newby, LK ;
Granger, CB ;
Lee, KL ;
Califf, RM ;
Simes, RJ ;
Van de Werf, F .
CIRCULATION, 2005, 111 (23) :E393-E393
[46]   Letter by Kielstein et al regarding article, "Renal function as a predictor of outcome in a broad spectrum of patients with heart failure" [J].
Kielstein, Jan T. ;
Cooke, John P. ;
Zoccali, Carmine .
CIRCULATION, 2006, 114 (06) :E242-E242
[47]   Letter regarding the article by Katz et al, "Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure" [J].
Lundberg, J ;
Weitzberg, E .
CIRCULATION, 2005, 112 (06) :E84-E84
[48]   Response to Letter Regarding Article, "Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial" [J].
Rigotti, Nancy A. ;
Pipe, Andrew L. ;
Benowitz, Neal L. ;
Arteaga, Carmen ;
Garza, Dahlia ;
Tonstad, Serena .
CIRCULATION, 2010, 122 (09) :E446-E446
[49]   Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes A Prespecified Secondary Analysis of a Randomized Clinical Trial [J].
Oyama, Kazuma ;
Raz, Itamar ;
Cahn, Avivit ;
Goodrich, Erica L. ;
Bhatt, Deepak L. ;
Leiter, Lawrence A. ;
McGuire, Darren K. ;
Wilding, John P. H. ;
Gause-Nilsson, Ingrid A. M. ;
Mosenzon, Ofri ;
Sabatine, Marc S. ;
Wiviott, Stephen D. .
JAMA CARDIOLOGY, 2022, 7 (09) :914-923
[50]   Efficacy and safety of dapagliflozin in ameliorating anemia in heart failure patients: A randomized controlled trial [J].
Bhaganagarapu, Laxmi Sankalpa ;
Sundararajan, Sarumathy ;
Munusamy, Vengatesh .
JOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH, 2024, 13 (04) :1245-1254
12345